Home Inns and Hotels delivers more than enough to send the "sell on the news" traders for a loop

08/10/2012 4:02 pm EST

Focus: STOCKS

Jim Jubak

Founder and Editor, JubakPicks.com

The ADRs (American Depositary Receipts) of Home Inns and Hotels Management (HMIN) dropped another 2.53% yesterday as traders continued to sell into the company’s after-the-close second quarter earnings report.

Surprise! The Chinese budget hotel company delivered enough to confound the sellers. And to disappoint those of us hoping to buy more on any sell-on-the-news dip. (Home Inns and Hotels Management is a member of my Jubak’s Picks portfolio http://jubakpicks.com/ )

The ADRs were headed to a gain of 4.15% in the minutes before the August 10 close.

The company reported earnings of 34 cents an ADR, 3 cents above the Wall Street consensus. Revenue came in at $228.2 million, well ahead of the $214.8 consensus. That was good enough for 60.2% revenue growth from the second quarter of 2011.

But what really turned sentiment, in my opinion, from sell on the news to got to get some was the company’s guidance for the third quarter of $243 million to $248 million in revenue—versus the $238.3 million consensus—and the increased guidance for all of 2012 of $899.6 to $914.5 million in revenue against the $871.9 million analyst consensus.

As of August 10 I’m raising my target price slightly to $34 a share by May 2013.

Full disclosure: I don’t own shares of any of the companies mentioned in this post in my personal portfolio. The mutual fund I manage, Jubak Global Equity Fund http://jubakfund.com/ , may or may not now own positions in any stock mentioned in this post. The fund did own shares of Home Inns and Hotels Management as of the end of March. For a full list of the stocks in the fund as of the end of March see the fund’s portfolio at http://jubakfund.com/about-the-fund/holdings/

Related Articles on STOCKS

Keyword Image
11 Reasons to Buy Microsoft
12/11/2017 5:00 am EST

For our latest recommendation, we revisit one of the world's most prominent technology companies, Mi...

Keyword Image
A Trio of Top-Tier Biotechs
12/11/2017 5:00 am EST

We hold three biotech stocks in our growth portfolio — Biogen (BIIB), Bioverativ (BIVV), and R...

Keyword Image
Saudis, Oil and ETFs
12/11/2017 5:00 am EST

Under the guise of clamping down on “widespread corruption,” Prince Mohammed bin Salman ...